Jean‐Pierre Boissel

Oral Beraprost Sodium, a Prostaglandin I ₂ Analogue, for Intermittent Claudication

Michel Lièvre, Sophie Morand, B. Besse et al. · Circulation · 2000 · 146 citations · Full text

Scientific and regulatory evaluation of mechanistic <i>in silico</i> drug and disease models in drug development: Building model credibility

Flora T. Musuamba, Ine Skottheim Rusten, R Lesage et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 133 citations · Full text

Engineering, Risk Model Validation, Verification +24

Effects of bisoprolol on heart rate variability in heart failure

Françoise Pousset, Xavier Copie, Philippe Lechat et al. · The American Journal of Cardiology · 1996 · 119 citations

Heart Failure, Cardiovascular Disease, Medicine +7

Considerations for the meta-analysis of randomized clinical trials

Jean‐Pierre Boissel, J Blanchard, E Panak et al. · Controlled Clinical Trials · 1989 · 118 citations

Meta-analysis, Clinical Trial Management, Clinical Trial Analysis +7

A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents

Benjamin Ribba, Olivier Saut, T. Colin et al. · Journal of Theoretical Biology · 2006 · 97 citations · Full text

Therapeutic Benefit, Engineering, Avascular Tumor Growth +11